FindTrial
Sign In

A study on combination of Paxil Tablet and benzodiazepines

A study on combination of Paxil Tablet and benzodiazepines

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080220053
Enrollment
150
Registered
2005-09-08
Start date
2005-09-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

investigational material(s) Generic name etc : Paxil tablet. INN of investigational material : Therapeutic category code : 117 Psychotropic agents Dosage and Administration for Investigational materi

Sponsors

GlaxoSmithKline K.K.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Main Inclusion criteria- .Male or Female patients .>=18 to <65 years old .Patients with depression or depressive episodes who are diagnosed to have major depressive disorders. .Patients with 14 or higher points in total scores for Items No.1 - 17 on HAM-D .Patients who have continuously received Benzodiazepine anxiolytics -Main Exclusion criteria- .Patients with a strong suicide tendency

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Primary endpoint is the extent and rate of decrease in HAM-D total score—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026